XLRN
Acceleron Pharma Inc
Price:  
178.75 
USD
Volume:  
7,201,419.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Acceleron Relative Valuation

-149.3%
Upside

As of 2024-02-24, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (88.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -149.3%.

The range of the Relative Valuation is (82.39) - (92.77) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 19.5x - 22.2x 20.8x
Forward P/E multiples 19.5x - 22.0x 21.0x
Fair Price (82.39) - (92.77) (88.11)
Upside -146.1% - -151.9% -149.3%
178.75 USD
Stock Price
(88.11) USD
Fair Price

Acceleron Relative Valuation - Historical P/E Data

Date P/E